维普期刊资源整合服务平台（V6.5）

71篇 您的检索式：作者名="Leitzel"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Elevated plasma endoglin(CD105) predicts decreased response and survival in a metastaticbreast cancer trial of hormone therapy 显示文摘	Vo MN Evans M Leitzel K	2010	Breast Cancer Res Treat2010，119，3：	1
2	Elevated serum c-erbB-2 anti- gen levels and decreased response to hormone therapy of breast cancer 显示文摘	Leitzel K Teramoto Y K0nrad K	1995	J Clin Oncol1995，13，5：	1
3	Elevated serum e-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer显示文摘	Leitzel K Teramoto Y Konrad K	1995	J Clin Oncol1995，13，4：	1
4	Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy 显示文摘	Lipton A Leitzel K Ali SM	2005	Cancer2005，104，2：	1
5	Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer显示文摘	Leitzel K Teramoto Y Konrad K	1995	J Clin Oncol1995，13，5：	1
6	Elavated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer显示文摘	Leitzel K	1995	J Clin Oncol1995，13，5：	1
7	Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer显示文摘	Ali SM Leitzel K Chinchilli VM	2002	Clin Chem2002，48，8：	1
8	Epidermal growth factor receptor mRNA in peripheral blood of patientswith pancreatic, lung, and colon carcinomas detected by RT-PCR显示文摘	Loren Clarke Kim Leitzel Jill Smith Suhail Ali Allan Lipton	2003	International Journal of Oncology2003，，2：	1
9	A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study显示文摘	Keay S Leitzell S Ochrzcin A	2012	BMCUrol2012，12，1：	1
10	Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen 显示文摘	Lipton A Ali SM Leitzel K	2003	J Clin Oncol2003，21，10：	1
11	HER-2/neu diagnostics in breast cancer显示文摘	Carney WP Leitzel K Ali S	2007	Breast Cancer Res2007，9，3：	1
12	Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy显示文摘	LIPTON A LEITZEL K ALI S M	2005	Cancer2005，104，2：	1
13	Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen显示文摘	Lipton A All SM Leitzel K	2003	J Clin On- col2003，21，10：	1
14	Serum HER - 2/neu and respouse to the aromatase inhibit or letrozole versus tamoxffen显示文摘	A Lipton SM Ali K Leitzel	2003	Journal of Clinical Oncology2003，21，10：	1
15	Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis显示文摘	Ali SM Demers LM Leitzel K	2004	Ann Oncol2004，15，3：	1
16	Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic,lung,and colon carcinomas detected by RT- PCR显示文摘	Clarke LE Leitzel K Smith J	2003	Int J Oncol2003，22，2：	1
17	Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen显示文摘	Lipton A Ali S M Leitzel K	2003	J Clin Oncol2003，21，10：	1
18	Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer 显示文摘	Lipton A Ali SM Leitzel K	2002	J Clin Oncol2002，20，6：	1
19	Elevated plasma tissue inhibitor of metallopmteinase - 1 level pr8ediets decreased response and survival in metastatic breast cancer显示文摘	Lipton A Ali SM Leitzel K	2007	Cancer2007，109，10：	1
20	Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen 显示文摘	Lipton A Ali SM Leitzel K	2003	J Clin Oncol2003，21，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示